Sterile product development company InnoPharma has commercially launched Cosyntropin Injection, 0.25mg/vial in the US.
Cosyntropin injection, 0.25mg/vial available in single-use vials is generic equivalent of Cortrosyn injection.
Cosyntropin injection is indicated for use as a diagnostic agent to detect patients with suspected adrenocortical insufficiency.
InnoPharma develops complex generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms.
Source:
http://drugdelivery.pharmaceutical-business-review.com/news/innopharma-launches-cosyntropin-injection-025mgvial-in-us-090413
